


Addiction Therapy Is Underprescribed but May Benefit Medical Adherence

Beyond Addiction: Medical Therapy for Addiction May Benefit Medical Adherence

Upadacitinib Receives Breakthrough Designation, Abatacept Use Expands in Australia & More
S.C. Sues Purdue, Maker of OxyContin, Over Deceptive Marketing

Rheumatology Drug Updates: Opana ER Painkiller Pulled from U.S. Market; Upadacitinib to Treat RA, and More
